Acquired by Astellas Pharma:
Iota is developing their “neural dust” technology to deliver targeted, effective therapy via small implants capable of neuromodulation. Their implants are battery-less, wireless, and about the size of a grain of rice, and they can be lodged onto specific nerves to both measure and stimulate activity.